TMO

Thermo Fisher Scientific
D

TMO

Arincen67/100B

Thermo Fisher Scientific company profile

CEO
Marc N. Casper
Employees
125,000
Headquarters
168 Third Avenue, Waltham, MA 02451, US
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO date
17 Mar 1980
Stock exchange
NYSE
ISIN
US8835561023

Website:thermofisher.com

About the company

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Employees

Thermo Fisher Scientific had about 125,000 employees at the end of fiscal year 2025 (31 December 2025), by its annual report. That is 0.0% more than a year before.

Employees Change on the year
Fiscal yearEmployeesChange on the yearRevenue per employeeNet income per employee
FY2025125,0000.00%356.46K USD53.90K USD
FY2024125,000+2.46%343.03K USD50.68K USD
FY2023122,000-6.15%351.29K USD49.14K USD
FY2022130,0000.00%345.50K USD53.46K USD
FY2021130,000+62.50%301.62K USD59.42K USD
FY202080,000+6.67%402.73K USD79.69K USD
FY201975,000+7.14%340.56K USD49.28K USD
FY201870,0000.00%347.97K USD41.97K USD
FY201770,000+27.27%298.83K USD31.79K USD
FY201655,000+5.77%332.26K USD36.76K USD
FY201552,000+1.96%326.26K USD37.99K USD
FY201451,000+2.00%331.17K USD37.15K USD
FY201350,000+28.53%261.81K USD25.47K USD
FY201238,900-1.02%321.59K USD30.28K USD
FY201139,300+5.65%298.37K USD33.84K USD
FY201037,200+5.08%290.02K USD27.84K USD
FY200935,400+2.61%285.58K USD24.02K USD
FY200834,500+4.55%304.29K USD28.82K USD
FY200733,000+8.20%295.35K USD23.06K USD
FY200630,500+165.22%124.32K USD5.54K USD
FY200511,500+16.16%228.96K USD19.41K USD
FY20049,900-8.33%222.83K USD36.55K USD
FY200310,800-0.92%194.18K USD18.52K USD
FY200210,900-9.17%——
FY200112,000-7.69%——
FY200013,000-48.82%——
FY200025,400+7.63%——
FY199923,600+5.36%——
FY199822,400+26.13%——
FY199617,760+23.33%——
FY199514,400+40.71%——
FY199410,234+16.30%154.91K USD10.10K USD
FY19948,800———

Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.

Who owns Thermo Fisher Scientific

Institutions such as funds, banks and insurers held 91.4% of Thermo Fisher Scientific's shares on 30 June 2026, 2,714 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.

Institutions 91.4%Other shareholders 8.6%

Common questions about Thermo Fisher Scientific

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.